Trial Profile

A phase 1b study of THB-001 for the treatment of Asthma

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 18 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs THB 001 (Primary)
Indications Asthma
Focus Adverse reactions

Most Recent Events

18 Nov 2022 New trial record
09 Nov 2022 According to a Third Harmonic Bio. media release, initial data expected to be reported in the second half of 2024.
09 Nov 2022 According to a Third Harmonic Bio. media release, company will submit a clinical trial application (CTA) in Canada for THB001 to support the initiation of a Phase 1b trial in asthma during the first half of 2023.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com